BioXcel TherapeuticsBTAI
那斯達克 · USD
1.06
-0.04
(-3.64%)
收盤 04/25 03:59 (UTC+8)
盤後
1.09
+0.03
(+2.83%)
04/25 03:59 (UTC+8)
BioXcel TherapeuticsBTAI
1.06
-0.04
(-3.64%)
財務數據
損益表
- 0.00
- 0.00
- 0.01
- 0.01
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -25.38
- 10.26
- 54.79
- 89.69
- -80.62
- 71.03
- -54.10
- -28.57
- -18.33
- 161.22
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 256 | 98 | 120 | 168 | 366 | 214 | 1,104 | 582 | 376 | 341 |
營業成本 | 32 | 11 | 107 | 14 | 832 | 1,170 | 61 | 80 | 714 | 512 |
營業毛利 | 224 | 87 | 13 | 154 | -466 | -956 | 1,043 | 502 | -338 | -171 |
營業費用 | 10,506 | 14,315 | 15,865 | - | 10,027 | - | - | - | 19,537 | 48,125 |
研發費用 | 6,701 | 8,740 | 10,256 | 4,554 | 5,901 | 5,101 | 8,032 | 11,401 | 9,934 | 19,619 |
推銷及管理費用 | 3,805 | 5,381 | 5,609 | 5,699 | 4,094 | 7,683 | 9,451 | 13,264 | 9,603 | 24,343 |
非經常性項目費用 | - | 194 | - | - | 32 | 1,553 | 856 | - | - | 4,163 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -10,282 | -14,228 | -15,852 | -10,099 | -10,493 | -15,293 | -17,296 | -24,163 | -19,875 | -48,296 |
其他收入及費用 | 2,133 | -12,310 | 887 | 6,838 | 3,666 | 5,433 | 12,697 | 979 | 1,054 | 1,062 |
利息費用 | 4,396 | 4,373 | 4,222 | 3,993 | 4,032 | 3,790 | 3,700 | 3,607 | 3,435 | 3,252 |
稅前純益 | -12,545 | -30,911 | -19,187 | -7,254 | -10,859 | -13,650 | -8,299 | -26,791 | -22,256 | -50,486 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -12,545 | -30,911 | -19,187 | -7,254 | -10,859 | -13,650 | -8,299 | -26,791 | -22,256 | -50,486 |
基本每股稅後盈餘(元) | 0.40 | -2.18 | -2.45 | -1.50 | -0.22 | -0.32 | -0.21 | -0.87 | -0.76 | -1.72 |
稀釋每股稅後盈餘(元) | 0.65 | -2.21 | -2.67 | -1.50 | -0.18 | -0.30 | -0.12 | -0.87 | -0.75 | -1.72 |
基本平均股數(千股) | 21959.00 | 14196.00 | 7843.00 | 4834.00 | 48624.00 | 42384.00 | 40256.00 | 30864.00 | 29448.00 | 29268.00 |
稀釋平均股數(千股) | 21959.00 | 14196.00 | 7843.00 | 4834.00 | 48624.00 | 42384.00 | 40256.00 | 30864.00 | 29448.00 | 29268.00 |
還原基本每股稅後盈餘(元) | 0.40 | -2.18 | -2.45 | -1.50 | -3.57 | -5.15 | -3.30 | -13.89 | -12.16 | -27.52 |
還原稀釋每股稅後盈餘(元) | 0.65 | -2.21 | -2.67 | -1.50 | -2.91 | -4.82 | -1.89 | -13.89 | -11.93 | -27.52 |
還原基本平均股數(千股) | 21,959 | 14,196 | 7,843 | 4,834 | 3,039 | 2,649 | 2,516 | 1,929 | 1,840 | 1,829 |
還原稀釋平均股數(千股) | 21,959 | 14,196 | 7,843 | 4,834 | 3,039 | 2,649 | 2,516 | 1,929 | 1,840 | 1,829 |
EBITDA(千元) | -7,606 | -26,023 | -14,497 | -2,835 | -6,528 | -9,677 | -4,426 | -23,063 | -18,436 | -46,778 |